TRPA1 and melanoma: Recent studies have shown TRPA1 agonists to promote cell survival at low levels (Schaefer et al. 2013), but equally, may inhibit proliferation of melanoma cells (Oehler et al. 2012) and actually promote pro-proliferation gene expression patterns within human keratinocytes (Atoyan et al. 2009).